Y Okayama

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI
    Y Okayama
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 166:4705-12. 2001
  2. ncbi request reprint Further characterization of FcgammaRII and FcgammaRIII expression by cultured human mast cells
    Y Okayama
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 1881, USA
    Int Arch Allergy Immunol 124:155-7. 2001
  3. ncbi request reprint Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge
    D D Hagaman
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892 1881, USA
    Am J Respir Cell Mol Biol 25:685-91. 2001
  4. ncbi request reprint IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma
    M R Woolhiser
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1881, USA
    Eur J Immunol 31:3298-307. 2001

Collaborators

  • D D Metcalfe
  • M R Woolhiser
  • A M Gilfillan
  • D D Hagaman
  • C Prussin
  • C D'Ambrosio

Detail Information

Publications4

  1. ncbi request reprint A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI
    Y Okayama
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 166:4705-12. 2001
    ....
  2. ncbi request reprint Further characterization of FcgammaRII and FcgammaRIII expression by cultured human mast cells
    Y Okayama
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 1881, USA
    Int Arch Allergy Immunol 124:155-7. 2001
    ..The expression of FcgammaRII and FcgammaRIII by human mast cells remains to be fully examined...
  3. ncbi request reprint Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge
    D D Hagaman
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892 1881, USA
    Am J Respir Cell Mol Biol 25:685-91. 2001
    ..These findings demonstrate that huMCs produce and release IL-1ra after Fcalpha RI aggregation, which may contribute to a local inhibition of IL-1-dependent effects on inflammation in the lung...
  4. ncbi request reprint IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma
    M R Woolhiser
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1881, USA
    Eur J Immunol 31:3298-307. 2001
    ..Activation of huMC thus may occur via monomeric IgG and FcgammaRI thereby providing a novel paradigm for huMC recruitment into inflammation...